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SUMMARY STATEMENT  
Human naïve pluripotent stem cells acquire competence for multilineage 
differentiation following a developmental trajectory comparable to primate embryonic 




Human naïve pluripotent stem cells (PSC) share features with pre-implantation 
epiblast. They thus provide an unmatched opportunity for characterising the 
developmental programme of pluripotency in Homo sapiens. Here we confirm that 
naïve PSC do not respond directly to germ layer induction, but must first acquire 
competence. Capacitation for multi-lineage differentiation occurs without exogenous 
growth factor stimulation and is facilitated by inhibition of Wnt signalling. Whole 
transcriptome profiling during this formative transition highlights dynamic changes in 
gene expression, affecting many cellular properties including metabolism and 
epithelial features. Notably, naïve pluripotency factors are exchanged for post-
implantation factors, but competent cells remain devoid of lineage-specific 
transcription. The gradual pace of transition for human naïve PSC is consistent with 
the timespan of primate development from blastocyst to gastrulation. Transcriptome 
trajectory during in vitro capacitation of human naïve cells tracks the progression of 
epiblast during embryogenesis in Macaca fascicularis, but shows greater divergence 
from mouse development. Thus the formative transition of naïve PSC in a simple 
culture system may recapitulate essential and specific features of pluripotency 





Pluripotency refers to a flexible potential for individual cells to give rise to all lineages 
of the embryo. This property is a foundational feature in amniote embryogenesis 
(Sheng, 2015). Pluripotency extends from initial emergence of the epiblast a few 
days after fertilisation until lineage commitment during gastrulation. The period varies 
from around 4 days in mouse and other rodents to 8-10 days or longer in primates, 
including Homo sapiens, and in many other mammals. Over this time, pluripotent 
cells change in character from the initial naïve condition to a lineage-primed state 
poised for commitment (Morgani et al., 2017; Nakamura et al., 2016; Nichols and 
Smith, 2009; Smith, 2017). This dynamic transition is manifest at the cellular level by 
epithelialisation and molecularly by reconfiguration of transcriptome, epigenome and 
metabolism (Bedzhov and Zernicka-Goetz, 2014; Buecker et al., 2014; Kalkan et al., 
2017; Mohammed et al., 2017; Zhou et al., 2012).  
Cultures of pluripotent stem cells (PSC) can be derived from embryos (Evans and 
Kaufman, 1981; Martin, 1981; Thomson et al., 1998) or generated by molecular 
reprogramming (Takahashi and Yamanaka, 2006). Different PSC phenotypes 
present a spectrum of pluripotent states (Enver et al., 2009; Hackett et al., 2017; 
Hackett and Surani, 2014; Hough et al., 2014; Nichols and Smith, 2009), some of 
which show correspondence with stages of in vivo progression of epiblast, while 
others may be artefactual products of the culture environment (Gokhale et al., 2015; 
Smith, 2013). In the mouse, canonical embryonic stem (ES) cells cultured in defined 
conditions are considered to be counterparts of the naïve epiblast from which they 
are derived (Boroviak et al., 2014; Brook and Gardner, 1997). Mouse post-
implantation epiblast-derived stem cells (EpiSC) (Brons et al., 2007; Tesar, 2005) in 
contrast resemble gastrulating epiblast of the anterior primitive streak (Kojima et al., 
2014; Tsakiridis et al., 2014), and are accordingly classified as primed (Nichols and 
Smith, 2009). Human and other primate PSC, as conventionally established and 
propagated, are overtly different from mouse ES cells and are transcriptionally 
distinct from pre-implantation epiblast (Nakamura et al., 2016; Rossant, 2015; 
Rossant and Tam, 2017; Yan et al., 2013). They display post-implantation features 
(Nakamura et al., 2016) although positioning on the developmental axis is uncertain, 
both because of variation between cell lines and culture conditions and because 
there is no human reference available for early post-implantation embryogenesis. 
Recently, culture conditions have been devised that sustain human PSC with many 
of the expected properties of naïve pluripotency  (Takashima et al., 2014; 
Theunissen et al., 2016; Theunissen et al., 2014). Naïve cells can be generated by 
resetting conventional PSC (Guo et al., 2017), by somatic cell reprogramming 
(Kilens et al., 2018; Liu et al., 2017), or by derivation directly from dissociated human 
inner cell mass cells (Guo et al., 2016). They exhibit transcriptome correlation with 
pre-implantation epiblast (Nakamura et al., 2016; Stirparo et al., 2018) and show 
protein expression of naïve epiblast-specific transcription factors such as KLF4, 
KLF17 and TFCP2L1 (Guo et al., 2016; Takashima et al., 2014).  
Human naïve PSC provide an opportunity for simulation of the developmental 
programme of human pluripotency prior to gastrulation. They may thereby open a 
window into events during the second week of gestation that cannot be 
characterised or even observed in human embryos in utero. This is a period of major 
change that appears critical for establishing differentiation competence (Rossant and 
Tam, 2017; Sheng, 2015; Smith, 2017). Notably, mouse naïve ES cells do not 
differentiate directly into germ cell or somatic lineages, but first transit through the 
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peri- and early post-implantation phase of epiblast development (Hayashi et al., 
2011; Kalkan et al., 2017; Mulas et al., 2017). During this formative transition, naïve 
cells are proposed to gain competence for lineage induction through a process of 
capacitation (Kalkan and Smith, 2014; Smith, 2017). In mouse ES cells, capacitation 
occurs within 24-48 hours (Hayashi et al., 2011; Mulas et al., 2017), reflecting the 
rapid rate of peri-implantation development in rodents (Acampora et al., 2016). For 
primate naïve PSC, the process may be expected to extend over several days, in 
line with slower embryogenesis (Nakamura et al., 2016; Smith, 2017). However, 
current methods for capacitating naïve PSC require prolonged culture for more than 
20 days to achieve robust multilineage differentiation (Guo et al., 2017). The 
developmental relevance of this protracted conversion is further questioned by poor 
viability, cellular heterogeneity, and rather low efficiency. Here we set out to 
determine conditions under which naïve PSC may recapitulate in utero progression 
to late epiblast, fully competent for germ layer induction. 
 
RESULTS 
Naïve hPSC do not respond immediately to somatic lineage induction  
Throughout this study we compared the conventional hESC line H9EOS with reset 
naïve derivative cR-H9EOS (Guo et al., 2017) and with the embryo derived naïve 
line HNES1 (Guo et al., 2016). We first tested multilineage differentiation via 
embryoid body formation in non-instructive serum-free conditions, a context 
permissive for the three primary germ layers. PSC were aggregated in suspension in 
N2B27 medium for up to 14 days. Conventional cells developed into typical embryoid 
body structures with downregulation of pluripotency markers NANOG and POU5F1 
(OCT4) and robust expression of markers of the three germ layers (Fig. 1A, B). 
Naïve cells formed fewer and smaller aggregates, with extensive cell death. They 
retained substantial expression of POU5F1 and NANOG while SOX17 and VIM 
differentiation markers were modestly upregulated, but markers for neuroectoderm, 
SOX1, PAX6, and MAP2, were not detected. The neural markers were also not 
expressed in outgrowths from naïve PSC aggregates (Fig. S1A). Thus, neural 
induction from naïve cells is not observed in embryoid body conditions, whilst other 
differentiation markers are lowly expressed.  
Embryoid body differentiation is dependent on efficiency of cell aggregation and cell-
cell interactions, parameters that are difficult to standardise. We therefore 
investigated the response of naïve cells to directed differentiation in adherent culture 
using protocols proven for conventional PSC. For these experiments naïve PSC 
were exchanged directly from self-renewal medium containing inhibitors of MEK/ERK 
and aPKC (Guo et al., 2017; Takashima et al., 2014) to the respective lineage 
induction media.  
For neuroectoderm induction we employed dual SMAD inhibition (Chambers et al., 
2009). By 10 days, quantification of SOX1 and PAX6 immunostaining by flow 
cytometry showed that H9EOS cultures comprise 90% neural lineage cells. In 
contrast, cR-H9EOS or HNES1 cultures contained fewer than 0.4% cells stained for 
either marker (Fig. 1C). Failure of direct neural induction is consistent with our 
previous observations on cR-Shef6 (Guo et al., 2017) and is further substantiated by 
absence of mRNA expression for SOX1, PAX6, BRN2, FOXG1 (Fig. 1D). Definitive 
endoderm induction (Loh et al., 2014) applied to conventional hPSC such as H9EOS 
or Shef6 generally results in around 90% CXCR4+ SOX17+ cells detected by flow 
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cytometry on day 3. In contrast, naïve PSC cultures remained negative for both 
markers (Fig. 1E), again consistent with previous observations (Guo et al., 2017). 
Naïve PSC also failed to upregulate mRNA for SOX17, CER1, HHEX, LHX1 and 
FZD8 (Fig. 1F). During paraxial mesoderm differentiation (Chal et al., 2016), 
conventional hPSC expand during the 6-day protocol (Fig. 1G), undergo epithelial-to-
mesenchymal transition (EMT), upregulate markers characteristic for paraxial 
mesoderm and EMT (TBX6, MSGN1, HES7, CDH2, SNAI1, ZEB1, ZEB2, VIM), and 
downregulate epithelial CDH1 (Fig. 1H). In contrast, naïve PSC showed high levels 
of cell death and the few remaining cells did not adopt mesenchymal morphology, 
lacked EMT markers, retained expression of CDH1, and showed no or little 
upregulation of PM markers (Fig. 1G, H). 
We further assessed the fate of naïve PSC exposed to differentiation conditions, 
either via embryoid body formation (Fig. S1B) or by monolayer induction of 
neuroectoderm or definitive endoderm (Fig. S1C). Naïve and general pluripotency 
markers (KLF4, KLF17, TFCP2L1, OCT4, NANOG) were downregulated in most 
cases, although still detectable. Genes characteristic of post-implantation epiblast 
such as TCF15, SOX11 and HES1 (Boroviak et al., 2015; Nakamura et al., 2016) 
were generally upregulated, although to variable levels. These observations indicate 
that upon withdrawal from self-renewing conditions a proportion of naïve PSC may 
progress towards a post-implantation formative epiblast identity irrespective of 
environment.  
These findings confirm and extend previous indications (Guo et al., 2017; Liu et al., 
2017) that human naïve PSC lack competence to respond productively to inductive 
cues for lineage specification. 
 
Naïve hPSC begin transition following withdrawal from self-renewal culture  
We have previously shown that naïve hPSC are able to differentiate into somatic 
lineages following a period of adaptation to culture in conventional hPSC media, 
such as mTESR, FGF/KSR or E8 (Guo et al., 2017; Takashima et al., 2014). 
Therefore, we surmise that naïve hPSC can be capacitated for somatic lineage 
induction, a process we have termed formative transition (Smith, 2017). However, 
this transition is accompanied by significant cell death and considerable cellular 
heterogeneity in the above conditions, and moreover takes longer than 20 days 
before stabilisation in a conventional PSC-like state (Guo et al., 2017). We therefore 
sought to achieve capacitation with improved consistency and efficiency, and over a 
developmentally more relevant time scale. 
We first compared capacitation in E8, which contains TGFβ and FGF2 (Chen et al., 
2011), with transition in N2B27 without added growth factors. In both conditions, a 
proportion of cells acquired and maintained flattened epithelioid morphology similar 
to conventional hPSC during the first 7 days. However, we observed that cell survival 
was much improved in N2B27. In E8 cells could be propagated further, albeit with 
considerable cell death, and eventually stabilise in a conventional PSC-like state. In 
contrast, in N2B27 the population became increasingly heterogeneous after day 7, 
and by day 12 all cells appeared differentiated and ceased proliferation (Fig. 2A).  
We tested ability to re-form naïve colonies after periods in E8 or N2B27. Cells were 
re-plated at clonal density in naïve PSC culture conditions each day after switching 
to E8 or N2B27, and alkaline phosphatase-positive colonies were scored 5-7 days 
later. In both media, the proportion of cells capable of colony formation dropped 
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markedly during the first 3 days (Fig. 2B). We monitored expression of pluripotency 
genes by RT-qPCR (Fig. 2C). In both media naïve-specific transcription factors KLF4 
and TFCP2L1 were downregulated over 3 days while KLF17 reduced more 
gradually. OCT4 and NANOG declined less and then stabilised from day 7 in E8 but 
continued to fall in N2B27. SOX2 was relatively stable in E8 but downregulated 
progressively in N2B27. 
We assayed monolayer differentiation into neuroectoderm and definitive endoderm 
after 7 days of treatment, when cells in N2B27 or E8 appear similar. Both 
populations produced SOX1-positive neuroectodermal cells and CXCR4/SOX17 
double positive endoderm (Fig. 2D). However, the efficiencies of differentiation from 
multiple independent experiments were variable and generally low, with maximum 
values around 27% for neuroectoderm and 50% for definitive endoderm (Fig. 2E). In 
contrast we have previously shown that longer term culture (>20 days) in E8 results 
in efficiencies of 80-90% for both lineages, comparable to conventional PSC (Guo et 
al., 2017).  
These results indicate that naïve cells can reach somatic lineage competence over 7 
days, with or without provision of exogenous FGF and TGFβ, but these conditions 
are only partially effective. 
 
Inhibition of WNT signalling facilitates capacitation 
At day 7 we noted a significant fraction of TBXT (Brachyury) expressing cells that 
were exclusive to NANOG-positive cells (Fig. 2F, G). TBXT is a known target of 
canonical Wnt signalling (Yamaguchi et al., 1999). We also detected expression of 
Wnt ligands and pathway components (Fig. S2). We therefore examined whether 
endogenous WNT activity might disrupt or divert the transition process. We tested 
capacitation in N2B27 supplemented with the tankyrase inhibitor XAV939 (2μm), 
which blocks canonical Wnt signalling (Huang et al., 2009). In contrast to cultures in 
N2B27 alone or E8, we observed relatively uniform establishment of epithelial 
morphology similar to conventional hPSC throughout the culture in the presence of 
XAV939 (Fig. 3A). Cells expanded continuously throughout this conversion (Fig. 3B). 
Moreover, unlike in N2B27 only, proliferation was sustained for at least 20 days. 
Thereafter, the cultures could still be maintained, but became heterogeneous. We 
found that addition of FGF2 and activin A to XAV939 (hereafter XAF) after day 10 
allowed for continued propagation with minimal overt differentiation for at least 50 
days (Fig. S3). XAF is similar to medium used for culturing mouse EpiSC as more 
homogeneous populations (Sumi et al., 2013; Tsakiridis et al., 2014). 
Colony assay showed that the ability to self-renew in naïve conditions was greatly 
diminished after 2 days in N2B27 plus XAV and almost eliminated by day 3, similar 
to cultures in N2B27 only or E8 (Fig. 3C). Likewise, naïve pluripotency factor (KLF4, 
TFCP2L1) transcripts were reduced to a very low or undetectable level over this 
period, while KLF17 declined more slowly and was extinguished only by 10 days of 
transition. In distinction to cultures in N2B27 alone, however, NANOG and POU5F1 
expression stabilised from day 7 at similar levels to those observed in conventional 
hPSC (Fig. 3D). We also noted that DPPA3 was downregulated from day 6 onwards. 
These observations were substantiated by immunostaining (Fig. 3E, F).  
We tested directed differentiation after 10 days in XAV939 when cells display a 
pluripotency marker profile similar to conventional PSC. Upon dual SMAD inhibition, 
we observed robust upregulation of PAX6 and SOX1, as shown by immunostaining 
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and quantified by flow cytometry (Fig. 4A, B). The efficiency was comparable to 
conventional hPSC. RT-qPCR confirmed expression of these markers, along with 
BRN2, MAP2, FOXG1 (Fig. 4C). These cells could be further differentiated to post-
mitotic neurons, validated by immunostaining for TUBB3 (β-III-tubulin), MAP2, 
NEUN, and RT-qPCR for MAP2, NEUN, NCAM1 and ASCL1 (Fig. S4A, B). 
Definitive endoderm induction was also highly efficient, assayed by immunostaining 
for SOX17 and FOXA2 (Fig. 4D), and by flow cytometry which quantified co-
expression of CXCR4 and SOX17 in 83.0% of cells (Fig. 4E). Importantly the 
primitive endoderm marker PDGFRa (Blakeley et al., 2015; Plusa et al., 2008; 
Stirparo et al., 2018; Yan et al., 2013) was not induced (Fig. S4C). RT-qPCR showed 
expression of definitive endoderm markers at levels similar to induction from 
conventional hPSC (Fig. 4F). Differentiation could be continued to PDX1-expressing 
foregut progenitors, with efficiencies >80% (Fig. S4D). Finally, in response to 
paraxial mesoderm induction, lineage markers and EMT genes were upregulated 
while CDH1 was downregulated. TBX6 and CDX2 protein expression was confirmed 
by immunostaining (Fig. 4G). Paraxial mesoderm identity was substantiated by 
further differentiation to myotubes with expression of transcripts for sarcomeric 
proteins TTN and DMD (Fig. S4E). Immunostaining for sarcomeric myosin showed 
striated myofibers (Fig. S4F) and spontaneous contractions confirmed functional 
sarcomere assembly (Movie 1). 
We repeated capacitation with XAV939 on multiple naïve PSC, including: embryo-
derived HNES1, HNES5c1 and HNES5c5; reset ESC, cR-H9EOS and cR-S6EOS; 
reset iPSC, cR-LQT1. Lineage competence was consistently achieved across 
multiple independent experiments (Fig. S5, for selected cell lines) (Table S1). 
XAV939 is a potent tankyrase (TNKS1 and 2) inhibitor (Huang et al., 2009), which 
stabilizes the axin-GSK3β complex resulting in degradation of β-catenin, but 
potentially can affect other cellular pathways (Lehtio et al., 2013). In order to confirm 
that capacitation is facilitated specifically by inhibition of the Wnt pathway, we tested 
an alternative mode of inhibition. IWP2 and C59 act on porcupine (PORCN) to 
prevent Wnt processing and secretion (Chen et al., 2009; Proffitt et al., 2013). Naïve 
hPSC cultured in N2B27 with C59, or IWP2, also produced cells with flat epithelioid 
morphology (Fig. S6A) that displayed similar multi-lineage competence as cells 
cultured with XAV939 (Fig. S6B-F). 
PSC capacitated in XAV939 for 10 days could be further propagated for multiple 
passages in either XAF or E8 without signs of growth arrest or differentiation. In 
either media cells maintained their abilities to produce derivatives of three germ 
layers with efficiencies similar to conventional PSC, even >33d after initiation of 
transition (Fig. S7) 
From these results we conclude that Wnt inhibition facilitates formative transition of 
human naïve cells. By 10 days, cells appear fully capacitated to produce 
neurectoderm, endoderm and mesoderm lineage precursors that can undergo 
further differentiation into tissue progenitors and post-mitotic cell types.  
 
Global gene expression profiling during capacitation of naïve hPSC 
To characterise gene expression dynamics during capacitation, we performed whole 
transcriptome RNA sequencing at days 0, 1, 2, 3, 7 and 10 (Fig. S8A). In addition, on 
day 10 cells were split into two conditions for continued maintenance, E8 or XAF 
medium, and passaged until 22-28 days in total (indicated as d22+). Conventional 
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H9EOS hESC in E8 were used as a reference. We prepared biological triplicate 
samples for all cell lines and conditions. 
Pearson correlation analysis based on all expressed genes divided samples into two 
major populations; early, day 0-3, and late, day 7 onwards (Fig. S8B). HNES1 and 
cR-H9EOS samples were highly correlated over the entire time course, indicating a 
shared trajectory. We determined the number of variable genes for all pairwise 
comparisons, which confirmed that differential expression increased markedly 
between early and late samples (Fig. S8C).  
We further examined expression dynamics after 10 days, following transfer to either 
E8 or XAF. Pearson correlation analysis of samples on day 10, day 22+, and control 
cells, reveals overall similarity with correlation coefficients greater than 0.95 in all 
comparisons (Fig. S8D). PCA shows two major groups correlating to the culture 
conditions; E8 medium or XAV939-containing media (Fig. S8E). Of note, cR-H9EOS 
cells capacitated and then maintained in E8 medium are most similar to conventional 
H9EOS hESC cultured in E8. Thus, following capacitation naïve cells can regain 
their original conventional PSC state in terms of global gene expression if they are 
expanded in comparable culture conditions. 
We examined the dynamics of gene expression during the time course. PCA for all 
variable genes confirmed that HNES1 and cR-H9EOS follow similar trajectories (Fig. 
5A). Biological triplicates showed high consistency. We then generated a list 
comprising all genes differentially expressed between any two time points of the time 
course and in at least one cell line (padj<0.01; fold change >2). Soft clustering 
analysis distinguished 5 major clusters, identified by minimizing the total variation 
within each cluster (Fig. S9A): 1 – “early down”, 2 – “late down”, 3 – “up-n-dn, 4 – 
“early up”, 5 – “late up”, (Fig. 5B, C). We compared the clusters between the two cell 
lines, considering genes of the same and similar clusters. Similar clusters are those 
in which genes changed expression in the same direction, but with different 
dynamics: cluster 1 and 2 (downregulated); clusters 4 and 5 (upregulated). For the 
two cell lines, 61.7% of genes belonged to the same clusters, and 83.9% were in the 
same and similar clusters (Fig. 5D, E). PCA showed proximity between the same 
clusters, indicating that not only the dynamics, but also the levels of gene expression 
are similar between the two cell lines (Fig. S9B). 
We inspected representation of KEGG pathways related to the clusters (Fig. S9C). 
We noted that genes related to oxidative phosphorylation are mostly downregulated 
(clusters 1 and 2) while those associated with glycolysis show no prevailing direction 
of change (Fig. S10A, Table S6). We used TMRE staining to assay mitochondrial 
membrane potential and observed reduced activity in capacitated compared with 
naïve PSC (Fig. S10B-D). This is in accord with reduction of mitochondrial 
respiration observed during formative transition in mouse (Fiorenzano et al., 2016; 
Kalkan et al., 2017; Zhou et al., 2012). Genes related to focal adhesion, cell-cell 
adhesion, ECM-receptor interactions and adherent junctions were predominant in 
the upregulated clusters (4 and 5). We inspected expression of a panel of genes 
associated with tight junctions, cell polarity, integrins and cadherins and observed 
that many are upregulated, some continuously but others only after day 3 or even 
later (Fig. S11). An exception is Cdh1 (E-cadherin), which is downregulated but still 
expressed. These data highlight gain of epithelial features as a major aspect of 
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formative transition in vitro, consistent with development of a laminar epithelial 
epiblast disk in the early post-implantation embryo (Sheng, 2015). 
We inspected expression of ligands and receptors of the TGF-β family and noted 
that both nodal and the convertase furin are down-regulated at the end of transition, 
while TGFBR1 (ALK5), TGFBR2 and ACVR2 receptors gain expression (Fig. S12). 
These dynamics are consistent with the requirement for exogenous activin for robust 
expansion after capacitation. 
Dynamics of selected genes were then assessed (Fig. 5E). Genes characteristic for 
naïve epiblast, such as KLF4, TFCP2L1, DNMT3L, FGF4, and KLF17 (Stirparo et 
al., 2018; Takashima et al., 2014), were downregulated to very low levels. Broader 
expressed pluripotency factors NANOG and POU5F1 were partially downregulated 
while SOX2 expression was relatively constant. These results are consistent with 
RT-qPCR and immunofluorescence analyses. We noted that DNMT3B was 
upregulated early whereas DNMT3A expression was maintained at a similar level 
(Fig. S12). Markers characteristic for early post-implantation epiblast (Boroviak et al., 
2015; Nakamura et al., 2016) were among the upregulated genes, including SOX11, 
FZD7, CDH2, and SALL2. We also evaluated genes that differ in expression 
between mouse and primate post-implantation epiblast. Among genes reported as 
specific for mouse early post-implantation stages (Boroviak et al., 2015), some were 
not upregulated (FGF5, POU3F1, NODAL), whereas others showed mild 
upregulation (SOX3 and SOX4). On the other hand, markers distinctive for primate 
post-implantation epiblast were upregulated, among them TCF7L1 (encoding TCF3) 
and FGF2. Of note, most early lineage markers, such as SOX1, PAX6, CDX2, 
GATA4, GATA6, SOX17, FOXA2 showed very low or undetectable expression, even 
at the end of the time course. Only TBXT and MIXL1 were found at low but 
detectable levels. Furthermore, this profile was maintained after extended expansion 
in E8 or XAF (Fig. S13). We validated dynamics of gene expression during formative 
transition by RT-qPCR analysis of independent experiments using HNES1, 
HNES5c2 and cR-H9EOS cell lines (Fig. S14). This also revealed that while cells at 
day 7 and 10 of capacitation share many features, some genes such as KLF17, 
TCF7L1 and CDH2 show ongoing expression changes between these timepoints, 
indicating that up to 10 days are required to achieve a stable profile. 
These analyses reveal a global and dynamic reconfiguration of gene expression 
during formative transition, with implications for metabolism, transcriptional 
regulation and cell biological properties. 
 
Comparison of gene expression dynamics between in vitro capacitation and in 
utero progression of primate epiblast 
To assess concordance between in vitro capacitation and formative transition in vivo, 
we compared our transcriptome results to the published single cell RNAseq data for 
early embryogenesis in the mouse (Boroviak et al., 2018; Mohammed et al., 2017) 
and the cynomolgus monkey, Macaca fascicularis (Nakamura et al., 2016). From the 
mouse embryo dataset, we used cells of pre-implantation (day 4.5, EPI), early (day 
5.5, post-E) and late (day 6.5, post-L) post-implantation epiblast. From the macaque 
embryo, we selected cells assigned as pre-implantation (EPI), early post-
implantation (post-E) and late post-implantation (post-L) epiblast in the original study. 
For both species, we selected variable genes during epiblast progression (padj<0.01, 
fold change >2) and identified 5 clusters of genes with distinct dynamic behaviour by 
soft clustering analysis (Fig. 6A).  
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We compared dynamics of gene expression in the clusters of the embryonic epiblast 
progression with the in vitro time course. We noted that clusters 1, 2, 4 and 5 
showed comparable behaviour between mouse and macaque embryo and hPSC, 
and could be regarded as equivalent. Cluster 3 genes behaved slightly differently. In 
mouse and macaque embryos, these genes were upregulated from EPI to post-E, 
then downregulated in post-L, but maintained at higher level than in EPI. In contrast, 
most genes of cluster 3 of the in vitro time course showed similar expression at the 
start and end points. Therefore, we considered two groups of similar clusters: 
downregulated (embryo 1 and 2, and hPSC 1 and 2); upregulated (embryo 3, 4 and 
5, and hPSC 4 and 5). Examination of overlap between the clusters of dynamic 
genes during the hPSC transition and mouse embryo revealed that a significant 
proportion of genes belonged to the same (28.9%) or similar clusters (66.3%). 
Furthermore, comparison of the hPSC transition with macaque embryo showed a 
greater overlap, 39.0% of variable genes were in the same clusters and 83.1% were 
in similar clusters (Fig. 6B).  
Among genes with similar dynamics during capacitation of hPSC and in both mouse 
and macaque embryos are: KLF4 and SPIC, downregulated; GBX2, up and down; 
SOX11, ETV4 and ETV5, upregulated (Fig. 6C). Genes dynamically expressed in 
hPSC and macaque that were not detected in the mouse and have not been 
characterised in the context of pluripotency progression include DLL3 and GLI2. 
Overall, therefore, in vitro capacitation of hPSC shares gene expression features 
with mouse but more closely resembles development of primate epiblast. 
We further focused on the comparison of the formative transition of hPSC in vitro 
and macaque embryo epiblast in utero. We performed PCA with hPSC during 
transition time course and the embryo cells from ICM, EPI, post-E and post-L stages. 
The two datasets are separated in PC1, which can be attributed to differences in 
methodology (single cell vs bulk RNAseq, alternative sequencing chemistries), 
species and environment. PC2 and PC3 reflect gradual progression in the embryo 
from ICM to EPI, then to post-E and finally to post-L (Fig. 6D). Naïve hPSC are 
closest to the EPI, consistent with previous analyses (Nakamura et al., 2016; 
Stirparo et al., 2018), and further during in vitro capacitation hPSC align with the 
progression of embryonic epiblast. We validated these results by comparing samples 
during capacitation to the embryo stages EPI, post-E, post-L (Fig. 6E, F). Gene 
expression for the embryo samples was calculated as average values of single cells. 
Using quadratic programming (Gong and Szustakowski, 2013), we measured 
relative similarities of hPSC samples to EPI, post-E and post-L. Similarity to EPI 
decreased continuously during capacitation. Fraction of similarity to post-E increased 
during the early steps of the time course (d1-3) and then reduced on day 7-10. 
Conversely, similarity to post-L remained relatively low during day 0-3, and increased 
on days 7 and 10. Therefore, the trajectory of in vitro capacitation follows to the 
progression of embryonic epiblast of non-primate embryo in utero. 
 
DISCUSSION 
Our results demonstrate that human naïve PSC are not equipped to enter directly 
into lineage specification but must first undergo a formative transition. During this 
capacitation process, PSC down-regulate naïve pluripotency transcription factors, 
rewire metabolism and signalling pathways, develop epithelial character, and 
become fully competent for differentiation to embryonic lineages. At the end of this 
transition cells exhibit dependence on exogenous FGF and activin/TGFβ for 
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continued expansion. Capacitation takes up to 10 days and follows a trajectory and 
timeline reflective of the progression of primate epiblast from ICM to gastrulation. 
These findings are consistent with the postulate of naïve pluripotency as a tabula 
rasa, in which potential for multi-lineage differentiation is created, but not actuated 
(Nichols and Smith, 2009; Smith, 2017).  
Classically, pluripotency is considered as the capacity of single cells to form all 
embryonic lineages with no predetermination. Highlighting capacitation as a pre-
requisite for multi-lineage differentiation accords with a more refined concept, in 
which pluripotency refers to potential rather than actual capacity. Naïve pluripotent 
cells can ultimately give rise to all cell types of the body, but only via an obligate 
transition during which competence is instated. Until recently this distinction has 
been obscured by the compression of events in rapidly advancing mouse ES cell 
differentiation. Indeed, mouse ES cells have often been presented as responding 
directly to lineage cues. However, closer inspection has revealed that in reality naïve 
cells first lose ES cell identity and transit to a population, termed epiblast-like (EpiLC) 
or formative, that is enabled for lineage induction (Buecker et al., 2014; Hayashi et 
al., 2011; Hoffman et al., 2013; Kalkan et al., 2017; Mulas et al., 2017). When human 
naïve PSC are exposed directly to inductive environments, they show a 
heterogeneous response, including cell death, partial transition to post-implantation 
epiblast, and differentiation into miscellaneous phenotypes. Acquisition of 
competence is therefore a shared requirement for mouse and human naïve PSC.  
For mouse ES cells capacitation can proceed in medium without growth factors or 
inhibitors other than insulin. In human, however, this process is unreliable due to 
disruption by endogenous Wnt activity. Interestingly, and in contrast to mouse ES 
cells, human naïve PSC self-renewal may also be perturbed by Wnt signalling (Guo 
et al., 2011; Theunissen et al., 2016; Zimmerlin et al., 2016). Indeed, for most 
experiments in the present study we used human naïve PSC that had been 
maintained in the presence of XAV939 along with MEK and aPKC inhibitors 
(Bredenkamp et al., submitted). Regardless of the naïve PSC maintenance 
condition, we found that during capacitation continuous Wnt pathway inhibition 
markedly improves the efficiency and consistency of transition. This finding may 
relate to the known role of Wnt signalling in promoting axis formation and 
gastrulation (Huelsken et al., 2000; Liu et al., 1999; Morkel et al., 2003). Activation of 
the Wnt pathway via GSK3 inhibition is also a key component in two of the three 
lineage induction protocols for hPSC. Our findings indicate that prior to competence, 
transitional epiblast should be shielded from Wnt stimulation to avoid inappropriate 
gene induction and miscellaneous differentiation.  
The formative transition is considerably faster in mice than in primates, both in vitro 
and in the embryo. One contribution to different developmental timing may be the 
appropriation of TCF7L1 (TCF3) in mouse but not primate naïve epiblast (Boroviak 
et al., 2018). In mouse ES cells TCF3 acts as a potent repressor of naïve network 
transcription factors (Martello et al., 2012). Inhibition of glycogen synthase kinase 3 
supports mouse ES cell self-renewal principally by abrogating the repressor activity 
of TCF3 (Wray et al., 2011) and TCF3 depletion substantially delays mouse ES cell 
exit from naïve pluripotency (Betschinger et al., 2013; Guo et al., 2011; Pereira et al., 
2006). Without TCF3, therefore, human naïve cells lack the major accelerator of 
naïve state exit. Subsequent development of lineage competence is also slower in 
human, however, implicating additional determinants of overall transition timing. 
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The slower pace of formative transition in human may make the sequence of events 
easier to delineate and mechanistically dissect than in mouse. Indeed, whereas exit 
from the naïve state and gain of multilineage competence are difficult to dissociate in 
mouse ES cells (Mulas et al., 2017), they appear to be separated by several days in 
the human system. Accordingly, we identified two major waves of dynamic 
transcriptome change. Over the first 3 days the cells down-regulate a subset of naïve 
factors (KLF4, TFCP2L1) coincident with the reduction in ability to reform naïve 
colonies. Some post-implantation markers (TCF15, FGF2, HES1) are up-regulated 
early and oxidative phosphorylation components reduced. The end of this period 
marks the exit from naïve pluripotency for the bulk population. The second wave of 
transcriptional changes features loss of other naïve factors (KLF17, DPPA3 and 
DPPA5), marked up-regulation of multiple genes associated with epithelial function, 
and gain of TCF7L1 and TCF7L2, mediators in the canonical Wnt pathway. This 
complex profile indicates that the formative transition is wide-reaching and 
comprised of distinct steps.  
Gene expression dynamics during capacitation of naïve hPSC exhibit similarity with 
epiblast progression in a non-human primate embryo, arguing that the transition path 
is not merely an in vitro phenomenon. In the embryo, epiblast undergoes profound 
cellular and molecular changes during the peri-implantation and early post-
implantation period, preparatory to gastrulation (Acampora et al., 2016; Mohammed 
et al., 2017; Nakamura et al., 2016; Peng et al., 2016). Our transcriptome analyses 
indicate that hPSC acquire full competence for somatic cell differentiation once they 
reach a state that is similar to the late pre-gastrulation epiblast. During subsequent 
expansion in FGF2 with TGFβ or activin A, cells converge closer to conventional 
hPSC, consistent with elaboration of a growth factor driven stem cell phenotype.  
In summary, when shielded from Wnt signalling but exposed to ERK1/2 and aPKC 
activity that are inhibited during self-renewal (Takashima et al., 2014), human naïve 
PSC convert efficiently to a pluripotent condition that is empowered for specification 
and commitment. This competent state lacks overt transcriptional lineage priming, 
but can be reliably induced to undergo productive differentiation into endodermal, 
mesodermal and neuronal cell types. Furthermore, once acquired, multilineage 
competence can be stably maintained, similarly to conventional human PSC. At the 
technical level, this simple and reliable transition system provides a platform for 
systematic evaluation of the differentiation propensity and consistency of human 
naïve PSC and thereby for rigorous comparison with other types of hPSC culture. 
More fundamentally, the naïve PSC transition provides a window into a crucial phase 
of human embryogenesis that cannot be accessed in vivo. It will be of great interest 
to characterise the sequence of molecular events and the mechanisms that underlie 




MATERIALS AND METHODS 
Human pluripotent stem cell lines 
Experiments were performed in parallel throughout on the embryo derived naïve 
hPSC line HNES1 (Guo et al., 2016) and the reset naïve hPSC line cR-H9EOS (Guo 
et al., 2017). H9EOS cells, conventional H9 hESC (Thomson et al., 1998) carrying 
the EOS reporter (Guo et al., 2017), were used as reference. Validation experiments 
were carried out on two clonal embryo-derived naïve hPSC (HNES5c1 and 
HNES5c2; unpublished), and on reset hESC described in Guo et al., 2017 or reset 
iPSC (LQT1, (Chen et al., 2017; Moretti et al., 2010)) generated by the method of 
Guo et al., 2017. HNES cells were derived with informed consent under licence from 
the Human Embryology and Fertilisation Authority. 
hPSC Maintenance 
Cells were cultured throughout in a humidified incubator with 5% O2 and 7% CO2 at 
37oC. 
Naïve hPSC were maintained on irradiated mouse embryonic fibroblasts (MEF) 
feeder cells in N2B27 (for details see Supplementary Materials and Methods) 
supplemented with 1μM PD0325901, 10ng/ml human LIF (produced in house), 2μM 
Gö6983 (Tocris Bio-Techne, Cat. 2285), and either 0.3-1μM CHIR99021 (Guo et al., 
2016; Takashima et al., 2014) or 2μM XAV939 (Tocris Bio-Techne, Cat. 3748) (Guo 
et al., 2017). Geltrex (ThermoFisher Scientific, A1413302) was optionally added to 
the medium at a concentration 1μl/ml during re-plating. Cells were passaged using 
TrypLE (ThermoFisher Scientific, Cat. 12605028). ROCK inhibitor (10μM; Y-27632, 
Cat. 688000, Millipore) was added for 24 hours after passaging.  
Conventional hPSC were cultured in E8 medium (prepared in house according to 
(Chen et al., 2011) on Geltrex pre-coated plates and passaged using 0.5mM EDTA 
in PBS. 
Capacitation 
Prior to capacitation, naïve hPSC were passaged once without feeders in naïve PSC 
medium plus Geltrex at 1μl/cm2. For the formative transition, cells were dissociated 
with TrypLE and plated to Geltrex coated tissue culture plates at a seeding density 
1.6x104/cm2 in medium for naïve hPSC supplemented with 10μM ROCK inhibitor. 
After 48 hours, cells were washed with DMEM/F12 supplemented with 0.1% BSA. 
Capacitation was then performed in the following conditions: E8 medium; N2B27 
medium without supplementation; N2B27 supplemented with one of the following 
WNT inhibitors: 2μM XAV939 (Tocris Bio-Techne, Cat. 3748), or 1μM IWP2 (Tocris 
Bio-Techne, Cat. 3533), or 1μM WNT-C59 (Tocris Bio-Techne, Cat. 5148). Medium 
was renewed every 1-2 days. Cells were passaged at a 1:2 ratio at confluency using 
TrypLE and10μM ROCK inhibitor. Cells were replated for lineage induction after 10 
days, unless otherwise specified.  
For expansion after capacitation, cells were cultured in either E8 or N2B27 
supplemented with 2μM XAV939, 3ng/ml Activin A and 10ng/ml FGF2 (XAF medium, 
modified from (Sumi et al., 2013). The cells could also be maintained in capacitation 
conditions (2μM XAV939 in N2B27), but were prone to differentiation beyond 20 
days. During expansion, cells were cultured on Geltrex pre-coated tissue culture 
plates and passaged by dissociation with either 0.5mM EDTA or TrypLE. In the latter 
case, 10μM ROCK inhibitor was added for 24 hours after dissociation. 
Cells could be frozen during capacitation in N2B27 with 10% DMSO. ROCK inhibitor 
(10μM) was added for 24 hours after thawing. Cells were passaged after thawing 




For colony formation assay, cells were dissociated with TrypLE and plated to Gelterx 
coated 12-well plates at a density 1, 2 or 4x103 cells/well in naïve medium 
supplemented with 10μM ROCK inhibitor. After 5-7 days colonies were fixed and 
stained for alkaline phosphatase (Sigma-Aldrich, Cat. 86R). Whole well images were 
acquired using Olympus IX51 and CellSens software and colonies were scored 
either manually or automatically using Ilastik and Fiji software. 
In vitro differentiation 
Embryoid bodies. hPSC were aggregated in Aggrewell plates with 400μm 
microwells (Stem Cell Technologies, Cat. 34411) in N2B27 supplemented with 10μM 
ROCK inhibitor. After 2 days, aggregates were flushed from the wells in N2B27 
medium and transferred to non-adhesive 6-well plates for further culture in 
suspension. On day 7 aggregates were optionally plated to tissue culture grade 
plates coated with Geltrex for outgrowth differentiation. RT-qPCR analysis was 
performed on day 14 day. 
Neuroectoderm. Neuroectoderm was induced based on (Chambers et al., 2009) in 
N2B27 supplemented with 1μM A8301 (Tocris Bio-Techne, Cat. 2939) and 500nM 
LDN193189 (alternative name DM3189, Axon Medchem, Cat. 1509), for 10 days. 
For subsequent neuronal differentiation, cells were dissociated after 10 days, 
passaged to plates pre-coated with poly-L-ornithine and laminin (both from Sigma) in 
N2B27 at a density 105 cells/cm2, and cultured for an additional 30 days. 
Endoderm. Definitive endoderm was induced according to (Loh et al., 2014). Cells 
were cultured in CDM2 basal medium supplemented with 100ng/ml Activin A 
(produced in house), 100nM PI-103 (Tocris, Bio-Techne, Cat. 2930), 3µM 
CHIR99021, 10ng/ml FGF2 (produced in house), 3ng/ml BMP4 (Peprotech, Cat. 
120-05ET), 10µg/ml heparin (Sigma-Aldrich, H3149) for one day; then for the next 2 
days the following supplements were applied: 100ng/ml Activin A, 100nM PI-103, 
20ng/ml FGF2, 250nM LDN193189, 10µg/ml heparin. Further induction of foregut 
progenitors was performed according to (Rezania et al., 2014) with analysis at the 
S4 stage. 
Paraxial mesoderm. Differentiation to paraxial mesoderm and myotubes was 
performed according to (Chal et al., 2016). Cells were cultured in 3µM CHIR99021 
and 500nM LDN193189 for 6 days, with addition of 20ng/ml FGF2 from day 3-6. 
Multi-step induction of myotubes was continued up to 40 days of differentiation. 
Quantitative RT-PCR 
Total RNA was extracted using Reliaprep RNA Miniprep and 200-500ng used for 
reverse transcription using GoScript Reverse Transcription system (both from 
Promega). Quantitative PCR was performed with GoTaq qPCR Master Mix 
(Promega) using Universal Probe Library (Roche) or Taqman probes (ThermoFisher 
Scientific) for detection. Primer sequences and Taqman probes are listed in Tables 
S2 and S3. GraphPad Prism software was used for graphic representation. Each 
analysis was performed in parallel on separate cell lines and data are presented as 
means from technical duplicates for each line. 
Flow cytometry 
Cells were dissociated using Accutase and washed using PBS with 2% FCS. For 
surface marker staining, cells were incubated with directly conjugated antibodies 
(Table S4) diluted in PBS with 2% FCS for 30min at +4°C, followed by washing and 
resuspending in PBS. For intracellular marker staining, the cells were fixed with 
Fixation Buffer (00-8222-49, ThermoFisher Scientific) for 30min at +4°C, washed 
with Permeabilization Buffer (00-8333-56, ThermoFisher Scientific), and incubated 
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with antibodies diluted with Permeabilization Buffer and 5% donkey serum (Sigma-
Aldrich) for 1 hour at +4°C. Detection was performed using a BD LSRFortessa 
instrument (BD Biosciences) with analysis using FlowJo software. 
Immunofluorescence 
Fixation was performed with 4% formaldehyde in PBS for 15min, permeabilization 
with 0.5% Triton X-100 in PBS for 10min, blocking with 3% BSA and 0.1% Tween-20 
in PBS for 30min, all at room temperature. Antibodies (Table S5) were diluted in PBS 
with 0.1% Triton X-100 and 3% donkey serum. Incubation with primary antibodies 
was carried out overnight at +4°C, then secondary antibodies were added for 1 hour 
at room temperature. Slides were mounted using Prolong Diamond Antifade 
Mountant (Life Technologies ThermoFisher Scientific, Cat. P36970). 
Assessment of mitochondrial membrane potential. 
TMRM (Tetramethylrhodamine, methyl ester) was applied to cells in culture medium 
at 100nM for 30min at 37°C. Fluorescence was measured using flow cytometry, then 
an uncoupling agent of mitochondrial oxidative phosphorylation FCCP (carbonyl 
cyanide-p-trifluoromethoxyphenylhydrazone) was added to cell suspension at 1µM 
for 5 min and the measurement was repeated. 
Microscopy, image processing and quantification 
Immunofluorescent imaging was performed on a Leica DMI4000 microscope, or 
Andor Revolution XD spinning disk system for myotube visualisation. 
Immunofluorescent images of myotubes were deconvolved using Autoquant X3 
(MediaCybernetics), and Maximum Intensity Projections created using Imaris 
(Bitplane). For quantification of immunofluorescent staining for KLF17, NANOG, 
KLF4, OCT4, mean intensity of staining over identified DAPI nuclei was measured 
using Cell Profiler (Broad Institute). Movies were acquired using Leica DMI4000 
microscope, saved as .avi using Fiji software and then converted to .mp4 format. 
Library preparation and RNA sequencing  
Total RNA was prepared using Reliaprep RNA Miniprep kit (Promega). rRNA was 
depleted using Illumina's Ribozero HMR kit following the manufacturers protocol. 
Libraries were prepared using the KAPA Stranded mRNA-Seq Kit (Kapa Biosystems, 
Roche) on an Agilent Bravo liquid handling system and MJ thermocyclers. Libraries 
were sequenced on HiSeq 2500, single end 50bp reads. 
Transcriptome analysis 
Reads were aligned to human genome build GRCh38/hg38 with STAR 2.5.2b (Dobin 
et al., 2013) and human gene annotation from Ensembl release 87 (Yates et al., 
2016). Htseq-count (Anders et al., 2015) was used to quantify expression to gene 
loci. Mouse samples were compiled from an earlier study (Mohammed et al., 2017) 
and analysed as described in (Boroviak et al., 2018). Macaque FPKM expression 
table from the dataset published in (Nakamura et al., 2016) was provided by the 
authors. Orthology 1-to-1 for cross-species comparison was used. 
Cluster analysis and principal component analysis were computed using log2 FPKM 
values with the Bioconductor packages DESeq2 (Love et al., 2014) or FactoMineR 
(Lê et al., 2008) in addition to custom scripts. SCDE R package (Kharchenko et al., 
2014), was used to perform differential expression analysis. Fractional identity 
between the sample of the time-course and the selected embryo stages was 
determined via quadratic programming using the R package DeconRNASeq (Gong 
and Szustakowski, 2013). Average expression levels of cells comprising distinct 
macaque embryo stages were used as the ‘signature’ dataset, and the relative 
identity of each time-course sample was computed by quadratic programming. 
Enrichment of KEGG pathways was computed with custom script using the KEGG 
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database resource (https://www.genome.jp/kegg/). Soft clusters were computed with 
R package MFuzz (Futschik and Carlisle, 2005; Kumar and E.M., 2007) and elbow 
method was used to determine the appropriate number of clusters. In order to detect 
genes with the greatest expression variability, a non-linear regression curve was 
fitted between log2 FPKM expression and the square of coefficient of variation. 
Thresholds were applied along the x-axis (log2FPKM) and y-axis (logCV2) to identify 
the most variable genes. 
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Figure 1. Naïve hPSC do not respond to lineage differentiation cues  
(A) Aggregates cultured for 7 days in N2B27, unstained and stained with Trypan 
Blue; bright field, 10x. (B) RT-qPCR analysis of marker expression after 14 days of 
aggregation culture. Here and in all qPCR measurements, error bars are standard 
deviations of technical duplicates. (C) Flow cytometry analysis of intracellular marker 
staining after application of dual SMAD inhibition for neuroectoderm induction. (D) 
RT-qPCR analysis following dual SMAD inhibition. (E) Flow cytometry analysis of 
cell surface (CXCR4) and intracellular (SOX17) marker expression after application 
of definitive endoderm induction conditions. (F) RT-qPCR analysis in definitive 
endoderm induction conditions. (G) Cell counts in paraxial mesoderm induction 
conditions. Error bars are derived from 2 independent experiments. (H) RT-qPCR 
analysis following application of paraxial mesoderm induction protocol.  
Un – undifferentiated, EB – embryoid bodies. 
NE – neuroectoderm, DE – definitive endoderm, PM – paraxial mesoderm. 
 
Figure 2. Transition of naive hPSC in N2B27 only 
(A) Bright field images of naïve hPSC and cultures in N2B27 for 7 or 12 days, or in 
E8 for 14 days; 10x. (B) Colony counts after culture in N2B27 or E8 and replating at 
low density in naïve PSC conditions. (C) RT-qPCR analysis of pluripotency marker 
expression during culture in N2B27 or E8. (D) Flow cytometry analysis of 
neuroectoderm and definitive endoderm markers following induction after 7 days in 
N2B27 or E8. (E) Summary of efficiencies of differentiation after 7 days in N2B27 or 
E8, from multiple independent experiments. (F) RT-qPCR analysis of 
mesoendodermal marker expression after 7 days in N2B27 or E8. (G) 
Immunostaining for TBXT and NANOG on day 7 in the indicated conditions. 
 
Figure 3. Transition of naïve hPSC is facilitated by XAV939 
(A) Conventional hPSC and naive hPSC before and after culture in N2B27 plus 
XAV939 for 14 days; bright field, 10x. (B) Cell counts during transition in XAV939; 
error bars are standard deviations from 3 independent experiments. (C) Colony 
assay after culture in XAV939; performed as in Fig 2B. (D) RT-qPCR assay of 
pluripotency gene expression during transition in XAV939. (E) Immunofluorescent 
staining for pluripotency markers during transition in XAV939. H9 conventional hPSC 
provide reference staining. (F) Quantification of intensity of immunostaining. Mean 
intensity of cells stained with the secondary antibodies only was subtracted from 
measurement of each cell stained with specific antibodies. The resulted values of 
intensity above control are represented as boxplots. 
 
Figure 4. Differentiation competence of hPSC after formative transition in 
XAV939 
(A-C) Neuroectoderm induction after transition in XAV939, parallel treatment of 
conventional hPSC and naïve hPSC after capacitation. Neuroectoderm markers 
were examined by: (A) flow cytometry; (B) immunostaining, (C) RT-qPCR. (D-F) 
Definitive endoderm induction after transition in XAV939. Markers were examined 
by: (D) immunostaining; (E) flow cytometry; (F) RT-qPCR. (G-H) Differentiation to 
paraxial mesoderm after transition in XAV939. Markers were analysed by: (G) RT-




NE – neuroectoderm, DE – definitive endoderm, PM – paraxial mesoderm, Un – 
undifferentiated (conventional and capacitated hPSC that were not induced to 
differentiation). 
 
Figure 5. Global transcriptome analysis during formative transition  
(A) PCA of HNES1 and cR-H9EOS during formative transition. For each cell line 
three independent experiments are represented. (B) Heatmaps showing expression 
of variable genes assigned to 5 dynamic clusters, derived separately for HNES1 and 
cR-H9-EOS. (C) Numbers of protein coding genes, and of TF/coF/REM (transcription 
factors, co-factors and epigenetic remodellers), within the 5 dynamic clusters. (D) 
Comparison of gene content of clusters between HNES1 and cR-H9-EOS; 61.7% of 
genes belong to the same clusters and 83.9% belong to the same+similar clusters. 
(E) Heatmap of RNAseq expression values for selected genes during formative 
transition. 
 
Figure 6. Comparison of gene expression during formative transition of hPSC 
in vitro and M. fascicularis embryonic epiblast in utero. 
(A) Soft clustering analysis of variable genes during developmental progression of 
mouse and macaque epiblast in utero, and transition of hPSC in vitro; average level 
of gene expression per cluster is indicated. (B) Comparison of clusters of variable 
genes between progression of M. musculus or M. fascicularis epiblast in utero and 
hPSC in vitro. (C) Expression of selected genes during progression of mouse and 
macaque epiblast in utero and hPSC in vitro. (D) PCA of macaque epiblast single 
cells at different stages of development in utero and hPSC populations during 
formative transition in vitro. (E-F) fractions of similarity of hPSC during formative 
transition to embryonic stages EPI, post-E and post-L of the macaque embryo: (E) 
3D plot; (F) 2D projections.  
 
 
 
 






